Regulation of human papillomavirus gene expression by splicing and polyadenylation (Q38087843)

28 August 2017

Regulation of human papillomavirus gene expression by splicing and polyadenylation (English)

1 reference

28 August 2017

Cecilia Johansson

1

1 reference

28 August 2017

Stefan Schwartz

series ordinal

2

1 reference

28 August 2017

language of work or name

English

0 references

publication date

11 March 2013

1 reference

Nature Reviews Microbiology

28 August 2017

1 reference

28 August 2017

11

1 reference

28 August 2017

239-251

1 reference

28 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/nrmicro2984

28 August 2017

0 references

cites work

Papillomaviruses and cancer: from basic studies to clinical application

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

A review of human carcinogens--Part B: biological agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

The causal relation between human papillomavirus and cervical cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

The natural history of human papillomavirus infections of the mucosal epithelia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Epithelial cell responses to infection with human papillomavirus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

The papillomavirus life cycle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Human papillomavirus oncoproteins: pathways to transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Persistence of human papillomavirus infection: keys to malignant progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Initiation of DNA replication: lessons from viral initiator proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Human papillomavirus immortalization and transformation functions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Papillomavirus E5: the smallest oncoprotein with many functions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Human papillomaviruses and cervical cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Replication and partitioning of papillomavirus genomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Updating the natural history of human papillomavirus and anogenital cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

31 March 2020

HPV-16 RNA processing

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Papillomavirus genome structure, expression, and post-transcriptional regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Papillomavirus 3' UTR regulatory elements

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Regulation of translation in eukaryotic systems

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Development and validation of a novel reporter assay for human papillomavirus type 16 late gene expression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Current understanding of the mechanism of HPV infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Splicing of a cap-proximal human Papillomavirus 16 E6E7 intron promotes E7 expression, but can be restrained by distance of the intron from its RNA 5' cap.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Splice sites of human papillomavirus type 16 E6 gene or heterologous gene required for transformation by E7 and accumulation of E7 RNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

The large and small isoforms of human papillomavirus type 16 E6 bind to and differentially affect procaspase 8 stability and activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Alternative splicing of human papillomavirus type-16 E6/E6* early mRNA is coupled to EGF signaling via Erk1/2 activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Functional diversity of the hnRNPs: past, present and perspectives

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Intron definition and a branch site adenosine at nt 385 control RNA splicing of HPV16 E6*I and E7 expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

A few nucleotide polymorphisms are sufficient to recruit nuclear factors differentially to the intron 1 of HPV-16 intratypic variants.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Diagnosing Cervical Cancer and High-Grade Precursors by HPV16 Transcription Patterns

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Multiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 3'-splice site on the HPV-16 genome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Serine- and arginine-rich proteins 55 and 75 (SRp55 and SRp75) induce production of HIV-1 vpr mRNA by inhibiting the 5'-splice site of exon 3

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Human papillomavirus type 31b infection of human keratinocytes and the onset of early transcription.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

ESEfinder: A web resource to identify exonic splicing enhancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Control of the papillomavirus early-to-late switch by differentially expressed SRp20

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Serine/arginine-rich protein 30c activates human papillomavirus type 16 L1 mRNA expression via a bimodal mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

The gene encoding the splicing factor SF2/ASF is a proto-oncogene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Increased expression of cellular RNA-binding proteins in HPV-induced neoplasia and cervical cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

RNA splicing factors regulated by HPV16 during cervical tumour progression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

HPV16 E2 is an immediate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Induction of the human papillomavirus type 31 late promoter requires differentiation but not DNA amplification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Induction of the bovine papillomavirus origin "onion skin"-type DNA replication at high E1 protein concentrations in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Interaction of the papillomavirus E8--E2C protein with the cellular CHD6 protein contributes to transcriptional repression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

The E8--E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Early polyadenylation signals of human papillomavirus type 31 negatively regulate capsid gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Human Fip1 is a subunit of CPSF that binds to U-rich RNA elements and stimulates poly(A) polymerase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Human papillomavirus (HPV) type 18 induces extended growth in primary human cervical, tonsillar, or foreskin keratinocytes more effectively than other high-risk mucosal HPVs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Upstream regulatory region alterations found in human papillomavirus type 16 (HPV-16) isolates from cervical carcinomas increase transcription, ori function, and HPV immortalization capacity in culture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Adenovirus E4orf4 induces HPV-16 late L1 mRNA production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

HPV-16 E2 contributes to induction of HPV-16 late gene expression by inhibiting early polyadenylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Inefficient splicing of segment 7 and 8 mRNAs is an inherent property of influenza virus A/Brevig Mission/1918/1 (H1N1) that causes elevated expression of NS1 protein.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Polypyrimidine tract binding protein induces human papillomavirus type 16 late gene expression by interfering with splicing inhibitory elements at the major late 5' splice site, SD3632

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Translational properties of the human papillomavirus type-6 L1-coding mRNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Identification of a 17-nucleotide splicing enhancer in HPV-16 L1 that counteracts the effect of multiple hnRNP A1-binding splicing silencers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Inhibition of HPV-16 L1 expression from L1 cDNAs correlates with the presence of hnRNP A1 binding sites in the L1 coding region

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

The presence of inhibitory RNA elements in the late 3'-untranslated region is a conserved property of human papillomaviruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

The human papillomavirus type 31 late 3' untranslated region contains a complex bipartite negative regulatory element

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

AU-rich mRNA instability elements on human papillomavirus type 1 late mRNAs and c-fos mRNAs interact with the same cellular factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Inhibition of translation by UAUUUAU and UAUUUUUAU motifs of the AU-rich RNA instability element in the HPV-1 late 3' untranslated region

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Heterogeneous nuclear ribonucleoprotein C binds exclusively to the functionally important UUUUU-motifs in the human papillomavirus type-1 AU-rich inhibitory element

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

The RNA stability regulator HuR regulates L1 protein expression in vivo in differentiating cervical epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Inhibitory activity of the human papillomavirus type 1 AU-rich element correlates inversely with the levels of the elav-like HuR protein in the cell cytoplasm

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

The human immunodeficiency virus type 1 Rev protein and the Rev-responsive element counteract the effect of an inhibitory 5' splice site in a 3' untranslated region

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

SF2/ASF binds the human papillomavirus type 16 late RNA control element and is regulated during differentiation of virus-infected epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

The alternative splicing factor hnRNP A1 is up-regulated during virus-infected epithelial cell differentiation and binds the human papillomavirus type 16 late regulatory element.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Sequences homologous to 5' splice sites are required for the inhibitory activity of papillomavirus late 3' untranslated regions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

U1 snRNP inhibits pre-mRNA polyadenylation through a direct interaction between U1 70K and poly(A) polymerase.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Activity of the human papillomavirus type 16 late negative regulatory element is partly due to four weak consensus 5' splice sites that bind a U1 snRNP-like complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

The regulatory element in the 3'-untranslated region of human papillomavirus 16 inhibits expression by binding CUG-binding protein 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Specific inactivation of inhibitory sequences in the 5' end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Human papillomavirus type 16 capsid proteins produced from recombinant Semliki Forest virus assemble into virus-like particles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Inhibitory cis-element-mediated decay of human papillomavirus type 16 L1-transcript in undifferentiated cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Preferential binding of poly(A)-binding protein 1 to an inhibitory RNA element in the human immunodeficiency virus type 1 gag mRNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Multiple RNA splicing and the presence of cryptic RNA splice donor and acceptor sites may contribute to low expression levels and poor immunogenicity of potential DNA vaccines containing the env gene of equine infectious anemia virus (EIAV).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Viable adenovirus vaccine prototypes: high-level production of a papillomavirus capsid antigen from the major late transcriptional unit

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Mutational inactivation of two distinct negative RNA elements in the human papillomavirus type 16 L2 coding region induces production of high levels of L2 in human cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

HPV-16 L1 genes with inactivated negative RNA elements induce potent immune responses.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

High guanine and cytosine content increases mRNA levels in mammalian cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

DNA replicative functions of highly-expressed, codon-optimized human papillomavirus proteins E1 and E2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Codon optimization of the HPV-16 E5 gene enhances protein expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

A DNA vaccine encoding a codon-optimized human papillomavirus type 16 E6 gene enhances CTL response and anti-tumor activity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

tRNASer(CGA) differentially regulates expression of wild-type and codon-modified papillomavirus L1 genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Gene codon composition determines differentiation-dependent expression of a viral capsid gene in keratinocytes in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Listening to silence and understanding nonsense: exonic mutations that affect splicing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

The SR protein family of splicing factors: master regulators of gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Tissue-specific mechanisms of alternative polyadenylation: testis, brain, and beyond.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Pre-mRNA splicing in disease and therapeutics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Alternative splicing and evolution: diversification, exon definition and function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Role of viral splicing elements and cellular RNA binding proteins in regulation of HIV-1 alternative RNA splicing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2984

Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells

31 March 2020

1 reference

12 December 2020

mRNA instability elements in the human papillomavirus type 16 L2 coding region.

1 reference

12 December 2020

A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability

1 reference

12 December 2020

Translation of the human papillomavirus type 16 E7 oncoprotein from bicistronic mRNA is independent of splicing events within the E6 open reading frame

1 reference

12 December 2020

Hierarchy of polyadenylation site usage by bovine papillomavirus in transformed mouse cells.

1 reference

12 December 2020

The inhibitory activity of the AU-rich RNA element in the human papillomavirus type 1 late 3' untranslated region correlates with its affinity for the elav-like HuR protein.

1 reference

12 December 2020

Using an immortalized cell line to study the HPV life cycle in organotypic "raft" cultures.

1 reference

12 December 2020

Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b

1 reference

12 December 2020

Transcriptional termination between bovine papillomavirus type 1 (BPV-1) early and late polyadenylation sites blocks late transcription in BPV-1-transformed cells

1 reference

12 December 2020

The Rev protein of human immunodeficiency virus type 1 counteracts the effect of an AU-rich negative element in the human papillomavirus type 1 late 3' untranslated region.

1 reference

12 December 2020

Regulation of human papillomavirus type 31 polyadenylation during the differentiation-dependent life cycle

1 reference

12 December 2020

Analysis of human papillomavirus type 16 late mRNA 3' processing signals in vitro and in vivo

1 reference

12 December 2020

Human papillomavirus type 18 E1 protein is translated from polycistronic mRNA by a discontinuous scanning mechanism

1 reference

12 December 2020

Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA

1 reference

12 December 2020

An element in the bovine papillomavirus late 3' untranslated region reduces polyadenylated cytoplasmic RNA levels

1 reference

12 December 2020

Cancer burden in the year 2000. The global picture

1 reference

12 December 2020

In vitro systems for the study and propagation of human papillomaviruses

1 reference

12 December 2020

Differential effects of the splice acceptor at nucleotide 3295 of human papillomavirus type 31 on stable and transient viral replication.

1 reference

12 December 2020

Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1

1 reference

12 December 2020

Gene expression of genital human papillomaviruses and considerations on potential antiviral approaches.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRMICRO2984

1 reference

Dimensions Publication ID

28 August 2017

0 references

1 reference